The table below shows CHAMPIONS ONCOLOGY, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q4 2025
Q3 2025
Q2 2025
Q4 2024
Q3 2024
Q2 2024
Revenue
$16.56M
$15.04M
$13.99M
$17.04M
$13.49M
$14.06M
Cost of revenue
$8.83M
$7.26M
$8.00M
$6.62M
$7.43M
$7.07M
Gross profit
-
-
-
-
-
-
R&D
$2.27M
$2.62M
$2.08M
$1.72M
$1.69M
$1.45M
CSBR annual revenue (10-K history)
CHAMPIONS ONCOLOGY, INC. reported annual revenue of $56.94M for fiscal year 2025. That is up 13.5% from $50.16M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $20.24M (FY 2018) to $56.94M. Figures come from the company's audited annual reports as filed with the SEC.